文献速递消化、代谢与肾脏急症

静脉与口服对乙酰氨基酚治疗急诊成人急性疼痛:前瞻性双盲双模拟随机对照试验

Intravenous versus oral paracetamol for acute pain in adults in the emergency department setting: a prospective, double-blind, double-dummy, randomised controlled trial.
PubMed 文献 · Emerg Med J · 2017-12-15
一句话结论在急诊成人中重度疼痛中,静脉对乙酰氨基酚作为阿片类辅助用药在30分钟镇痛效果上未优于口服剂型。

该单中心前瞻性随机双盲双模拟对照试验纳入87例急诊中重度疼痛成人,随机接受静脉或口服对乙酰氨基酚。主要终点为30分钟视觉模拟量表(VAS)疼痛评分下降,临床显著变化定义为13 mm。两组30分钟VAS均下降达临床显著:静脉组16.0 mm(SD 19.1),口服组14.6 mm(SD 26.4),差值-1.4 mm(95%CI -11.6至8.8,P=0.79),无显著差异。次要终点包括干预后静脉阿片类药物给药、患者满意度、副作用及住院时长均无差异。

要点

  • 在急诊成人中重度疼痛中,静脉与口服对乙酰氨基酚30分钟VAS下降分别为16.0 mm与14.6 mm,差值-1.4 mm(95%CI -11.6至8.8,P=0.79),无显著差异。
  • 两组30分钟VAS下降均达到预设的13 mm临床显著变化阈值。
  • 干预后静脉阿片类药物给药、患者满意度、副作用及住院时长两组均无差异。
  • 该试验为单中心前瞻性随机双盲双模拟对照试验,最终分析87例,中位年龄43.5岁,女性59.8%。

适用人群与场景

  • 急诊科成人中重度疼痛患者,作为阿片类药物的辅助镇痛。
  • 单中心学术三级急诊科收治的患者。

诊断标准与关键阈值

  • 临床显著疼痛变化定义为VAS评分变化13 mm。
  • 主要终点为30分钟VAS疼痛评分下降。

研究设计与关键结果

  • 研究类型:前瞻性、随机、双盲、双模拟、对照试验;单中心学术三级急诊科;最终分析87例,中位年龄43.5岁,女性59.8%。
  • 总体平均基线VAS疼痛评分67.9 mm(±16.0)。
  • 主要终点30分钟VAS下降:静脉组16.0 mm(SD 19.1 mm)vs 口服组14.6 mm(SD 26.4 mm),差值-1.4 mm(95%CI -11.6至8.8,P=0.79),无显著差异。
  • 两组30分钟VAS下降均达到预设的13 mm临床显著变化阈值。
  • 次要终点:干预后静脉阿片类药物给药、患者满意度、副作用及住院时长两组均无差异。

证据类型、等级与局限

  • 证据类型:前瞻性随机双盲双模拟对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在本试验中静脉对乙酰氨基酚在镇痛疗效上未显示优于口服对乙酰氨基酚,住院时长、患者满意度、补救镇痛需求或副作用方面也无差异。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To determine if intravenous paracetamol was superior to oral paracetamol as an adjunct to opioids in the management of moderate to severe pain in the ED setting.

METHODS: A prospective, randomised, double-blind, double-dummy, controlled trial was conducted at a single academic tertiary care ED. Adult patients with moderate to severe pain were randomly assigned to receive either the intravenous paracetamol or oral paracetamol. The primary outcome was Visual Analogue Scale (VAS) pain reduction at 30 min. A clinically significant change in pain was defined as 13 mm.

RESULTS: 87 participants were included in the final analysis, with a median age of 43.5 years and 59.8% were female. Overall mean baseline VAS pain score was 67.9 mm (±16.0). Both formulations achieved a clinically significant mean pain score reduction at 30 min, with no significant difference between the groups with 16.0 mm (SD 19.1 mm) in the intravenous group and 14.6 mm (SD 26.4) in the oral group; difference -1.4 mm (95% CI -11.6 to 8.8, P=0.79). Secondary outcomes, including postintervention intravenous opioid administration, patient satisfaction, side effects and length of stay, did not differ between groups.

CONCLUSIONS: Overall, there was a small but clinically significant decrease in pain in each group. No superiority was demonstrated in this trial with intravenous paracetamol compared with oral paracetamol in terms of efficacy of analgesia and no difference in length of stay, patient satisfaction, need for rescue analgesia or side effects.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Furyk J, Levas D, Close B, et al. Intravenous versus oral paracetamol for acute pain in adults in the emergency department setting: a prospective, double-blind, double-dummy, randomised controlled trial. Emerg Med J. 2017. PMID: 29247042. doi:10.1136/emermed-2017-206787

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。